Skip to main content

Pramlintide acetate

08-10-2021 | Artificial pancreas systems | News

Fully closed-loop insulin delivery not yet a match for precise carb counting

A dual-hormone fully closed-loop system did not demonstrate non-inferiority to a hybrid system in a randomized trial, despite producing a high time in range, report the researchers.

28-06-2021 | ADA 2021 | Conference coverage | News

Pramlintide, prandial insulin co-formulation gives benefits of both in one injection

A co-formulation of pramlintide and a prandial insulin offers improved postprandial glucose control and weight loss, without an increased number of injections, show the results of a small crossover trial.

25-09-2020 | EASD 2020 | Conference coverage | News

Fully closed-loop insulin delivery edges closer with pramlintide–faster aspart system

A fully automated dual-hormone delivery system with pramlintide and faster-acting insulin aspart delivers overall glycemic control that is nearly as good as that achieved with a hybrid closed-loop system with the insulin only, report researchers at the virtual 56th EASD Annual Meeting.